J. J. Piek

Publication List Details

Period

1993 - 2006

Number

234

Co-Authors

Prevalence of myocardial ischaemia as assessed with myocardial perfusion scintigraphy in patients with diabetes mellitus type 2 and mild anginal symptoms (2006)

Wiersma, J.J., Verberne, H.J., Trip, M.D., Holt, W.L. Ten, Eck-Smit, B. Van, Piek, J.J., ...

Purpose: To determine the prevalence and predictors of reversible myocardial perfusion defects, indicative of myocardial ischaemia, in patients with mild, stable anginal complaints [ Canadian...

Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion (2006)

Vis, M.M., Sjauw, K.D., Koch, K.T., Tijssen, J.G.P., ...

In acute ST-elevation myocardial infarction (STEMI), patients with multivessel disease (MVD) are considered to be a subgroup with an increased risk of mortality compared with patients with...

Physiological basis of clinically used coronary hemodynamic indices (2006)

Spaan, J.A.E., Piek, J.J., Hoffman, J.I.E., Siebes, M.

In deriving clinically used hemodynamic indices such as fractional flow reserve and coronary flow velocity reserve, simplified models of the coronary circulation are used. In particular, myocardial...

Eosinophilic infiltration in restenotic tissue following coronary stent implantation (2006)

Rittersma, S.Z.H., Meuwissen, M., Koch, K.T., Winter, R.J. De, Piek, J.J., ...

Objectives: The aim of our study was to compare the histopathological features of restenotic tissue after balloon angioplasty and after stent placement. We emphasized on specific types of...

Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction (2006)

Meuwissen, M., Niessen, H.W.M., Koch, K.T., Winter, R.J. De, ...

Background: C reactive protein (CRP), an important serum marker of atherosclerotic vascular disease, has recently been reported to be active inside human atherosclerotic plaques. Aims: To investigate...

Pharmaceutical interventions to influence arteriogenesis: New concepts to treat ischemic heart disease (2006)

Hoefer, I.E., Piek, J.J., Pasterkamp, G.

Despite the technical progress in interventional techniques to overcome the harmful effects of ischemic heart disease there is still an urgent need for alternative, pharmaceutical treatment...

Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5 (2006)

Henriques, J.P., Remmelink, M., Baan, J., Vis, M.M., Koch, K.T., ...

Currently, the most used left ventricular (LV) support device is intra-aortic balloon counterpulsation. The percutaneous implantable Impella Recover LP 2.5 system is a novel LV (unloading) assist...

Granulocytc-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps (2006)

Grundmann, S., Hoefer, I., Ulusans, S., Bode, C., Oesterle, S., Tijssen, J.G., ...

Background: A growing number of patients suffer from peripheral artery disease (PAD). Current therapies are often limited by the extent of vascular pathology and the occurrence of restenosis after...

Time course of microvascular resistance of the infarct and noninfarct coronary artery following an anterior wall acute myocardial infarction (2006)

Bax, M., Winter, R.J. De, Koch, K.T., Schotborgh, C.E., Tijssen, J.G.P., Piek, J.J.

Previous studies have suggested that coronary flow velocity reserve (CFVR) in the early phase of acute myocardial infarction (AMI) is abnormal in infarcted and remote regions. This study determined...

CD44 Regulates Arteriogenesis in Mice and Is Differentially Expressed in Patients With Poor and Good Collateralization (2004)

Van Royen, N., Voskuil, M., Hoefer, I., Jost, M., De Graaf, S., Hedwig, F., ...

BACKGROUND: Arteriogenesis refers to the development of collateral conductance arteries and is orchestrated by circulating monocytes, which invade growing collateral arteries and act as suppliers of...

Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression (2003)

Van Royen, N., Hoefer, I., Bottinger, M., Hua, J., Grundmann, S., Voskuil, M., ...

Monocyte chemoattractant protein-1 (MCP-1) stimulates the formation of a collateral circulation on arterial occlusion. The present study served to determine whether these proarteriogenic properties...

Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial (2003)

Van Royen, N., Piek, J. J., Legemate, D. A., Schaper, W., Oskam, J., Atasever, B., ...

Peripheral arterial disease (PAD) affects a large percentage of the elderly population. Standard invasive treatment, apart from risk factor modulation, consists of bypass surgery or percutaneous...

Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits (2003)

Van Royen, N, Hoefer, I, Buschmann, I, Kostin, S, Voskuil, M, Bode, Ch, ...

Objective: The objective of our study was to quantify the arteriogenic potency of Monocyte Chemoattractant Protein-1 (MCP-1) under hyperlipidemic conditions. Additionally, we aimed to determine the...

Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome (2002)

Albertal, M., Sousa, J.E., Serruys, P.W., Belardi, J.A., Voskuil, M., Piek, J.J., ...

BACKGROUND: Because heterogeneous results have been reported, we assessed coronary flow velocity changes in individuals who underwent percutaneous transluminal coronary angioplasty (PTCA) and...

Value of coronary stenotic flow velocity acceleration in prediction of angiographic restenosis following balloon angioplasty (2002)

Albertal, M., Serruys, P.W., Regar, E., Langenhove, G. Van, Carlier, S.G., Piek, J.J., ...

INTRODUCTION: Quantitative angiographic assessment after balloon angioplasty is a poor predictor of immediate and long-term outcome. However, the measurement of blood flow velocity during angioplasty...

The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty (2002)

De Winter, R.J., Heyde, G.S., Koch, K.T., Fischer, J., Van Straalen, J.P., Bax, M., ...

Aims The acute phase reactant C-reactive protein is an important prognostic risk factor in patients with both stable and unstable coronary artery disease. The potential prognostic implications of an...

The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study (2001)

Piek, J.J, Boersma, E, Voskuil, M, Di Mario, C, Schroeder, E, Vrints, C, ...

Background There are limited data regarding the immediate and long-term effect of balloon angioplasty on the coronary flow reserve evaluated in a multicentre setting. Methods and Results A total of...

Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography (2000)

Piek, J.J, Boersma, E, Di Mario, C, Schroeder, E, Vrints, C, Probst, P, ...

Aims Evaluation of angiographical and intracoronary Doppler-derived parameters of coronary stenosis severity. Methods and Results A total of 225 patients with one-vessel disease were studied before...

Clinical events following excimer laser angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial (1998)

Appelman, Y.E., Swijndregt, E. Van, Lie, K.I., Gemert, M.J. Van, Piek, J.J., Redekop, W.K., ...

OBJECTIVES: To compare clinical outcome in patients with complex coronary lesions treated with either excimer laser coronary angioplasty (ELCA) or balloon angioplasty. PATIENTS AND DESIGN: 308...

Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting (1994)

MULDER, B. J. M., VAN DER DOEF, R. M., VAN DER WALL, E. E., TIJSSEN, J. G. P., PIEK, J. J., ...

From 1987 until 1991 a large prospective randomized multicentre study was performed in The Netherlands, Germany and Switzerland entitled CABADAS (Prevention of Coronary Artery Bypass graft occlusion...

Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques.

Van Der Wal, A. C., Becker, A. E., Koch, K. T., Piek, J. J., Teeling, P., Van Der Loos, C. M., ...

OBJECTIVE: To investigate the extent of plaque inflammation in culprit lesions of patients with chronic stable angina. DESIGN: Retrospective study. SETTING: Amsterdam reference centre. SUBJECTS: 89...

Does a waiting time for elective coronary angioplasty affect the primary success rate?

Koch, K. T., Piek, J. J., David, G. K., Mulder, K., Peters, R. J., Lie, K. I.

OBJECTIVE: To evaluate the effect of the waiting time for elective percutaneous transluminal coronary angioplasty (PTCA) on the primary success rate. SETTING: University hospital in The Netherlands....

Safety of low dose heparin in elective coronary angioplasty.

Koch, K. T., Piek, J. J., De Winter, R. J., David, G. K., Mulder, K., Tijssen, J. G., ...

OBJECTIVES: To evaluate the safety of a low dose of heparin in consecutive stable patients undergoing elective percutaneous transluminal coronary angioplasty (PTCA). DESIGN: Open prospective study in...

The negative inotropic and chronotropic effects of intravenous R 56865 during percutaneous transluminal coronary angioplasty.

Pijl, A J, Van Wezel, H B, Koolen, J J, Piek, J J, Koch, K, Swaan, A, ...

The present study was designed to evaluate the potential anti-ischaemic activity of R 56865 in patients with coronary artery disease, scheduled to undergo percutaneous transluminal coronary...

Role of plaque inflammation in acute and recurrent coronary syndromes

Meuwissen, M., Van Der Wal, A.C., Siebes, M., Koch, K.T., Chamuleau, S.A.J., Van Der Loos, C.M., ...

Inflammation plays an important role in the initiation, development, progression and complications of atherosclerotic vascular disease. Our present knowledge of the elementary role of inflammation...

Dutch guidelines for interventional cardiology: institutional and operator competence and requirements for training

Aengevaeren, W.R.M., Laarman, G.J., Suttorp, M.J., Ten Berg, J.M., Van Boven, A.J., De Boer, M.J., ...

Interventional cardiology is an expanding field within cardiovascular medicine and today it is generally accepted that cardiologists require specific training, knowledge and skills. Hospitals where...

Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells

Chamuleau, S.A.J., Vrijsen, K.R., Rokosh, D.G., Tang, X.L., Piek, J.J., Bolli, R.

Myocardial infarction results in loss of cardiomyocytes, scar formation, ventricular remodelling, and eventually heart failure. In recent years, cell therapy has emerged as a potential new strategy...